Thromboangiitis obliterans (TAO) occurs almost exclusively in young male smokers. Its involvement of the small and medium-sized arteries and veins leads to ischemic complaints and/or changes in the extremities. The possibility of organ involvement is a matter of controversy. The authors report a case of TAO with multiple organ involvement, including myocardial, splenic, and cerebral infarctions; pulmonary embolisms; and probable intestinal ischemia during a twenty-three-year course.
Get full access to this article
View all access options for this article.
References
1.
von Winiwarter F.: ueber eine eignenthuemliche Form von Endarteriitis und Endophlebitis mit Gangrän des Fusses. Arch Klin Ghir23: 202-226, 1879.
2.
Buerger L: thrombo-angiitis obliterans: A study of the vascular lesions leading to presenile spontaneous
3.
Bollinger A. , Hollmann B., Schneider E., et al: Thrombangiitis obliterans: Diagnosis and therapy in light of new immunological findings. Schweiz Med
4.
Leu HJ: Tromboangiitis obliterans Buerger. Schweiz
Berlit P., Kessler C., Reuther R., et al: New aspects of thromboangiitis abliterans (von Winiwarter-Buerger's
9.
Adar R., Papa MZ, Halpern Z., et al: cellular sensitivity to collagen in thromboangiitis obliterans . 19:1113-1116, 1983.
10.
Dasgupta A. , Roy MB, Talwar JR, et al: Immunoglobulins and complement 3 in patients with thrombangiitis obliterans. Indian J Med Res67:332-335, 1978
11.
Horsch AK, Horsch S., Morl H.: Diagnosis of thromboangiitis obliterans (Winiwarter Buerger disease) by detection of anti-elastin antibodies. Vasa14:5-9, 1985.
12.
Roncon deAlbuquerque R., Delgado L., Correira P., et al: Circulating immune complexes in Buerger's disease. Endarteritis obliterans in young mean. J Cardiovasc Surg ( Torino) 67:821-825, 1989.
13.
Smolen JS, Youngchaiyud U., Weidinger P., et al: Autoimmunological aspects of thromboangiitis obliterans (Buerger's disease). Clin Immunol Immunopathol11:168-177, 1978.
14.
Gulati SM, Singh KS, Thusoo TK, et al: Immunological studies in thrombo-angiitis obliterans (Buerger's disease). J Surg Res27:287-293, 1979.
15.
Ohno H., Matsuda Y., Takashiba K., et al: Acute myocardial infarction in Buerger's disease. Am J Cardiol57:690-691, 1986.
16.
Goldberg GA , Baranova MN, Pruzhanskii IA: Myocardial infarct in obliterating thromboangiitis . Klin Med (Mosk) 67:119-120, 1989.
17.
Hansner E., Allen EV: Generalized arterial involvement in thromboangiitis obliterans induding report of a case of thromboangiitis obliterans of a pul
18.
monary artery. Proc Mayo Clin15:7-23, 1940. 18. Biller J., Asconape J., Challas VR: A case for cerebral thromboangiitis obliterans . Stroke12:686-689, 1981.
19.
Schellong SM , Bernhards J., Ensslen F., et al: Intestinal type of thromboangiitis obliterans (Buerger's disease)J Intern Med235:69-73, 1994
20.
Lindenberg R. , Spatz H.: Ueber die Thrombarteriitis obliterans der Hirngefäße (cerebrale Form der von Winiwarter-Buergerschen Krankheit) . Virchows Arch Pathol Anat305:531-557, 1939.
21.
McLoughlin GA , Helsby CR, Helsby CC, et al: Association of HLA-A9 and HLA-B5 with Buerger's disease. Br Med J2:1165-1166, 1976.
22.
Rivera R.: Roentgenographic diagnosis of Buerger's disease. J Cardiovasc Surg15:40-46, 1973.
23.
Hagen B., Lohse S.: Clinical and radiologic aspects of Buerger's disease. Cardiovasc Intervent Radiol7:283-293, 1984.
24.
European Working Group on Critical Limb Ischemia : Second European Consensus Document on Chronic Critical Leg Ischemia. Circulation84 (suppl):IV-1-IV-22,1991.
25.
Fiessinger JN, Schafer M.: Trial of iloprost versus aspirin treatment for critical limb ischemia of thrombangiitis obliterans. The TAO Study. Lancet10:555-557,1990.
26.
Yephuny SN, Cyskin GJ: Hyperbaric oxygenation in treatment of peripheral disorders. Int Angiol4:207-210,1985.
27.
Gordon A., Zechmeister K., Collin J.: The role of sympathectomy in current surgical practice (review). Eur J Vasc Surg8:129-137, 1994.
